Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

EXTR Extreme Networks
$22.29 -1.42% -0.32
Notify me if price changes either direction
Interactive Brokers Logotype

Buy EXTR stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

Extreme Networks (EXTR)

Loading

Key Stats

Market cap. 2.9B
Enterprise value 3.0B
Trailing PE 57.97436
Forward PE 14.457354
PEG Ratio -0.17392308
Enterprise to EBITDA 29.242
Enterprise to revenue 2.262
Price to book MRQ 33.948948
Price to sales TTM 2.2566428

Financials

Fiscal Year Ends 2026-06-30
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 1.3B
EBITDA 85.7M
Diluted EPS TTM 0.39
Total Cash (MRQ) 244.5M
Current ratio (MRQ) 1.018
Operating Cash Flow (TTM) 182.6M

EXTR trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent EXTR News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.